Brain donations are transforming dementia research by revealing why Alzheimer's disease and related disorders progress differently in each person, offering hope for more precise diagnosis and treatment strategies. At Mayo Clinic Florida, one of the world's largest brain banks holds over 11,000 donated brains, allowing researchers to study the biological changes that drive cognitive decline in ways that living patients cannot provide.

What Are Tauopathies and How Do They Damage the Brain?

To understand dementia, scientists first need to understand tau, a protein that plays a critical structural role in brain cells. Dr. Melissa Murray, a professor of neuroscience at Mayo Clinic Florida, uses a helpful analogy to explain how tau works and what happens when it breaks down.

"I like to think about a railroad track. And the railroad track is what allows for our brain to bring messages and information all throughout. And tau is the nail that holds that railroad track down. But in certain brains, we think about that nail getting rusty. And so, those changes to the nail unfortunately can cause the railroad track to derail," explained Dr. Melissa Murray.

Dr. Melissa Murray, Professor of Neuroscience at Mayo Clinic Florida

When tau becomes damaged through a process called post-translational modifications, the protein misfolds and clumps together into aggregates. These clumps prevent the brain from sending messages and delivering nutrients to different regions, leading to cell degeneration and symptoms like memory loss and movement problems. Tauopathies is the broad term for diseases caused by these damaged tau proteins.

Do You Need Both Tau and Amyloid to Have Alzheimer's Disease?

Alzheimer's disease is unique among neurodegenerative disorders because it involves two distinct pathological changes, not just one. When Alois Alzheimer first described the disease over a century ago, he identified both tau tangles inside brain cells and amyloid plaques forming outside them. For a definitive diagnosis under the microscope, both must be present at significant levels.

However, the picture is more nuanced than simply having both proteins. As people age, subtle changes in tau and amyloid can occur naturally. The key difference in Alzheimer's disease is the severity and distribution of these changes across the brain. Primary tauopathies, by contrast, involve severe tau damage without the amyloid component.

How Brain Banks Advance Dementia Research and Treatment

Brain banks serve a critical function that living patients cannot provide. When researchers study a living person with dementia, they can observe symptoms and use imaging scans, but they cannot directly examine the brain tissue to confirm what is actually happening at the cellular level. Brain donations change that equation entirely.

At Mayo Clinic Florida's brain bank, the process begins with careful coordination between neuropathologists and neurologists. When a brain arrives, it is divided into two parts. One half is preserved in a fixed solution, allowing researchers to embed tissue samples in wax for microscopic study that can last for decades. The other half is frozen in one of 30-plus specialized freezers, enabling systematic categorization and analysis of genetic material and other biological markers.

The brain bank's unique structure includes several specialized sub-banks focused on different diseases:

• Alzheimer's Disease Bank: Dedicated to studying the tau and amyloid changes specific to Alzheimer's
• Tauopathy Bank: Focused on diseases driven primarily by tau protein damage
• Lewy Body Disease Bank: Examining alpha-synuclein protein changes that cause movement and cognitive problems

By studying brains from thousands of donors with different disease presentations, researchers can answer critical questions: Why do some people develop severe dementia while others with similar pathology remain relatively unaffected? What genetic factors protect some brains from decline? These insights are essential for developing treatments that work for individual patients rather than a one-size-fits-all approach.

How Brain Donation Supports Biomarker Discovery and Genetic Research

Brain tissue from donors enables researchers to develop biomarkers, which are measurable indicators of disease that can be detected in living patients through blood tests or imaging. Understanding the brain tissue directly helps scientists identify which biomarkers actually predict disease progression and which ones are merely incidental findings.

Genetic discoveries also depend heavily on brain bank research. When researchers can link specific genetic variations to the actual pathological changes observed in donated brain tissue, they can develop more targeted therapies and identify people at risk before symptoms appear. This is why donors who consent to genetic research are contributing to the future of preventive medicine.

Steps to Support Dementia Research Through Brain Donation

• Understand the Process: Brain donation involves a straightforward consent process coordinated by trained brain bank staff who explain how your brain will be used in research
• Discuss with Family: Talk with loved ones about your wishes and ensure they understand the importance of brain donation for advancing dementia research
• Register with a Brain Bank: Contact a major research institution like Mayo Clinic or a local university medical center to learn about their brain donation programs
• Specify Research Preferences: You can indicate whether you want your brain used for genetic research, specific disease studies, or general dementia research

The emotional significance of brain donation extends beyond the science. Dr. Murray's own grandmother, who had Alzheimer's disease, encouraged her granddaughter to pursue brain research and offered her own brain as the first donation. That personal connection underscores why families choose to donate: they want their loved one's experience to help others avoid the same fate.

What New Treatments Are Emerging From Brain Bank Research?

While brain banks provide the foundational knowledge, new therapies are beginning to emerge from this research. At Banner Alzheimer's Institute, an anonymous donor recently contributed $250,000 to expand access to an experimental drug therapy for cognitive decline. The drug was originally developed for ALS (amyotrophic lateral sclerosis) but is now showing promise in treating certain forms of dementia through a compassionate use program for patients who have not responded to other available treatments.

Additionally, researchers at Texas A&M University have developed a nasal spray that appears to reverse brain aging by reducing inflammation and restoring cellular energy. In early studies, the treatment improved memory and cognitive function after just two doses, with effects lasting for months. The therapy works by delivering microscopic biological particles called extracellular vesicles (EVs) directly into the brain through the nasal passage, bypassing the need for invasive procedures.

The nasal spray targets the inflammatory processes that damage aging brains. It suppresses inflammatory systems such as the NLRP3 inflammasome and the cGAS-STING signaling pathways, both strongly linked to age-related brain inflammation. The treatment also restores mitochondrial function, the energy-producing structures inside brain cells that decline with age.

"Brain age-related diseases like dementia are a major health concern worldwide. What we're showing is brain aging can be reversed, to help people stay mentally sharp, socially engaged and free from age-related decline," stated Dr. Ashok Shetty.

Dr. Ashok Shetty, University Distinguished Professor and Associate Director of the Institute for Regenerative Medicine at Texas A&M University

The implications are significant. In the United States, annual dementia cases are expected to increase from roughly 514,000 in 2020 to around 1 million by 2060. Treatments that can reverse or slow brain aging could dramatically reduce this burden. The Texas A&M research also found that treatment outcomes were consistent across both sexes, a finding researchers note is relatively uncommon in biomedical studies.

As dementia research accelerates, brain banks remain the essential foundation. They provide the tissue samples, genetic information, and detailed pathological data that allow scientists to understand why dementia develops differently in each person and to design treatments that work. For families affected by Alzheimer's and related dementias, brain donation offers a meaningful way to contribute to discoveries that could one day prevent or reverse the disease entirely.